Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MGNX
#3184
MacroGenics, Inc.
1.9
9
+1.53%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.53%
Monthly Change
+8.15%
6 month change
+13.71%
Year Change
-17.43%
Previous Close
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
Volume
16
Markets
US Stock Market
Healthcare
MGNX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenics Inc earnings beat by $0.68, revenue topped estimates
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates
Top 5 Oncology Stocks to Watch According to Barclays
MacroGenics stock initiated with Overweight rating by Barclays